Advertisement
Advertisement
ADAG
Adagene Inc. - ADR
4.11
USDSponsored
+0.04
+0.98%
Mar 26, 15:57 UTC -4
Closed
After-Market
4.11
0.00
0.00%
ADAG Earnings Reports
Positive Surprise Ratio
ADAG beat 0 of 2 last estimates.
0%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.32
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/-17.95%
Adagene Inc. - ADR earnings per share and revenue
On Mar 23, 2026, ADAG reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.91% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
FAQ
What were Adagene Inc. - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Adagene Inc. - ADR reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Adagene Inc. - ADR's Q4 2025 earnings?
The stock price moved down -7.91%, changed from $3.92 before the earnings release to $3.61 the day after.
When is Adagene Inc. - ADR expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Adagene Inc. - ADR's next earnings report?
Based on 3
analysts, Adagene Inc. - ADR is expected to report EPS of -$0.32 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement